Zhengye Biotechnology Holding L
ZYBT
Last
$1.61
Day
+38.8%
1y
-57.7%
5y
-76.3%
52w
-85.6%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
—
EMA 21
1.29
EMA 50
1.39
EMA 200
1.72
20d high
-25.8%
5y high
-92.0%
5y range
4th
Positions held
Your positionsZYBT isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-24
Hold
avoid
Signal
Strong Sell
Target
$1.30
Stop
$1.03
Stop distance
36.0%
Target vs last
-19.3%
Fundamentals
| Market cap | $54.50M | Enterprise value | $134.55M | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | 1.47 | Beta | — | Dividend yield | 0.00% |
| Revenue growth | -40.9% | Earnings growth | — | Gross margin | 20.5% | Operating margin | -77.0% |
| Profit margin | -60.0% | ROE | -25.2% | ROA | -9.5% | Debt / equity | 0.24 |
| Current ratio | 1.14 | Free cash flow | $39.58M | Analyst recommendation | none | Mean target | — |
| 52w high | $8.01 | 52w low | $0.62 |
Quarterly
No data yet.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $116M | $186M | $212M | $260M | — |
| Op margin | -58.7% | 9.2% | 22.5% | 25.4% | — |
| Net income | -$69.8M | $11.3M | $31.5M | $46.7M | — |
| Gross margin | 20.5% | 49.0% | 55.5% | 56.8% | — |
| Gross profit | $23.9M | $91.3M | $118M | $148M | — |
| Operating income | -$68.3M | $17.2M | $47.6M | $66.1M | — |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-08-06 · Zhengye Biotechnology Holding Limited Regains Compliance with Nasdaq Bid Price Requirement
2026-07-23 · Top Premarket Gainers
2026-07-22 · Top Premarket Decliners
2026-07-21 · Top Midday Decliners
2026-07-21 · Zhengye Biotechnology Says No Material Events Behind Unusual Trading Activity (NASDAQ:ZYBT)
2026-07-21 · Zhengye Biotechnology Holding Limited Comments on Unusual Trading Activity
2026-07-21 · Top Premarket Decliners
Price (daily)
Full chart · RSI · MACD · patternsZYBT · daily-10.2% over 13 sessions
Close EMA21 EMA50 EMA200